NRAS and glioblastoma: circASAP1 overexpression promotes glioblastoma cell proliferation and TMZ resistance via the circASAP1/miR-502-5p/NRAS regulatory network, indicating that circASAP1 is a potential target for TMZ-resistant glioblastoma therapy (121).